Frithiof R, Eriksson S, Rundgren M
Department of Physiology and Pharmacology, Karolinska Institutet, Stockholm, Sweden.
Acta Physiol (Oxf). 2007 Sep;191(1):25-34. doi: 10.1111/j.1748-1716.2007.01720.x. Epub 2007 Jun 5.
To investigate the contribution of cerebral mu-, kappa- and delta-opioid receptors in causing the hypotension, bradycardia and renal hypoperfusion evoked by haemorrhage.
Adult conscious ewes were bled continuously from a jugular vein until mean arterial blood pressure (MAP) was reduced to below 50 mmHg. Starting 30 min before and continuing until 60 min after haemorrhage either artificial cerebrospinal fluid (control), d-Phe-Cys-Tyr-d-Trp-Orn-Thr-Pen-Thr-NH(2) (CTOP micro-receptor antagonist), ICI 174,864 (delta-receptor antagonist) or nor-binaltorphimine dihydrochloride (nor-BNI, kappa-receptor antagonist) were infused intracerebroventricularly. In a randomized crossover fashion the effect of antagonizing one central opioid receptor subtype was compared to control experiments in the same animal (n = 6 in all groups).
Compared to corresponding controls, nor-BNI and ICI 174,864 significantly increased the haemorrhage volume needed to reduce MAP to below 50 mmHg (+4.7 mL kg(-1), SD 1.8 and +3.1 mL kg(-1), SD 3.0 respectively). In the nor-BNI group this was accompanied by a significantly augmented tachycardia before MAP fell. Both nor-BNI and ICI 174,864 also postponed haemorrhagic bradycardia and prolonged adequate blood flow to the kidney. The infusions did not affect the circulation per se or the recovery after haemorrhage. The micro-opioid receptor blockade had no effect on baseline circulation or the response to haemorrhage.
Activation of kappa- and delta-opioid receptors adjacent to the ventricular compartment contributes to initiating haemorrhagic hypotension and bradycardia in conscious sheep. However, other parts of the brain and different receptors are likely to play a role as well.
研究脑内μ、κ和δ阿片受体在出血引起的低血压、心动过缓和肾灌注不足中的作用。
成年清醒母羊经颈静脉持续放血,直至平均动脉血压(MAP)降至50 mmHg以下。在出血前30分钟开始,持续至出血后60分钟,向脑室内注入人工脑脊液(对照组)、d -苯丙氨酸-半胱氨酸-酪氨酸-d -色氨酸-鸟氨酸-苏氨酸-苯丙氨酸-苏氨酸-NH₂(CTOP微受体拮抗剂)、ICI 174,864(δ受体拮抗剂)或盐酸去甲丁丙诺啡(nor - BNI,κ受体拮抗剂)。采用随机交叉方式,将拮抗一种中枢阿片受体亚型的效果与同一动物的对照实验进行比较(所有组n = 6)。
与相应对照组相比,nor - BNI和ICI 174,864显著增加了将MAP降至50 mmHg以下所需的出血量(分别为+4.7 mL·kg⁻¹,标准差1.8和+3.1 mL·kg⁻¹,标准差3.0)。在nor - BNI组中,这伴随着MAP下降前显著增强的心动过速。nor - BNI和ICI 174,864还推迟了出血性心动过缓,并延长了肾脏的充足血流时间。这些注入对循环本身或出血后的恢复没有影响。微阿片受体阻断对基线循环或出血反应没有影响。
脑室周围κ和δ阿片受体的激活有助于引发清醒绵羊的出血性低血压和心动过缓。然而,大脑的其他部分和不同的受体可能也发挥了作用。